SODIUM NITROPRUSSIDE

N/A

Manufactured by EXELA PHARMA SCIENCES, LLC

1,403 FDA adverse event reports analyzed

Last updated: 2026-04-15

About SODIUM NITROPRUSSIDE

SODIUM NITROPRUSSIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by EXELA PHARMA SCIENCES, LLC. The most commonly reported adverse reactions for SODIUM NITROPRUSSIDE include RENAL FAILURE, PAIN, INJURY, ANXIETY, UNEVALUABLE EVENT. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SODIUM NITROPRUSSIDE.

Top Adverse Reactions

RENAL FAILURE74 reports
PAIN63 reports
INJURY60 reports
ANXIETY59 reports
UNEVALUABLE EVENT56 reports
FEAR54 reports
DRUG INEFFECTIVE53 reports
RENAL INJURY45 reports
EMOTIONAL DISTRESS44 reports
ANHEDONIA42 reports
TOXICITY TO VARIOUS AGENTS41 reports
RENAL IMPAIRMENT39 reports
STRESS39 reports
HYPOTENSION33 reports
MULTI ORGAN FAILURE33 reports
DEATH25 reports
DEPRESSION24 reports
HYPERTENSION20 reports
CEREBROVASCULAR ACCIDENT19 reports
RESPIRATORY FAILURE17 reports
ANAEMIA14 reports
CARDIAC ARREST14 reports
OFF LABEL USE14 reports
MENTAL STATUS CHANGES12 reports
NAUSEA12 reports
ARRHYTHMIA11 reports
CONDITION AGGRAVATED11 reports
PNEUMONIA11 reports
RENAL FAILURE ACUTE11 reports
LACTIC ACIDOSIS10 reports
LOSS OF CONSCIOUSNESS10 reports
MYOCARDIAL INFARCTION10 reports
PLEURAL EFFUSION10 reports
PYREXIA10 reports
SEPSIS10 reports
THROMBOCYTOPENIA10 reports
ATRIAL FIBRILLATION9 reports
BLOOD CREATININE INCREASED9 reports
CARDIAC FAILURE9 reports
CARDIAC FAILURE CONGESTIVE9 reports
DYSPNOEA9 reports
VOMITING9 reports
ACUTE KIDNEY INJURY8 reports
BRADYCARDIA8 reports
DIARRHOEA8 reports
HEPARIN INDUCED THROMBOCYTOPENIA8 reports
POST PROCEDURAL COMPLICATION8 reports
TACHYCARDIA8 reports
TREATMENT FAILURE8 reports
BLOOD PRESSURE DECREASED7 reports
BLOOD UREA INCREASED7 reports
DRUG INTERACTION7 reports
HYPERTENSIVE CRISIS7 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME7 reports
VENTRICULAR FIBRILLATION7 reports
VENTRICULAR TACHYCARDIA7 reports
AGITATION6 reports
ASTHENIA6 reports
BLOOD CYANIDE INCREASED6 reports
CARDIOGENIC SHOCK6 reports
DECREASED APPETITE6 reports
DEEP VEIN THROMBOSIS6 reports
DELIRIUM6 reports
FATIGUE6 reports
GASTROINTESTINAL HAEMORRHAGE6 reports
HAEMOGLOBIN DECREASED6 reports
HYPONATRAEMIA6 reports
OEDEMA PERIPHERAL6 reports
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME6 reports
ABDOMINAL DISTENSION5 reports
ALANINE AMINOTRANSFERASE INCREASED5 reports
BLOOD GLUCOSE INCREASED5 reports
CARDIOMEGALY5 reports
COAGULOPATHY5 reports
CONFUSIONAL STATE5 reports
CONSTIPATION5 reports
ENCEPHALOPATHY5 reports
GENERAL PHYSICAL HEALTH DETERIORATION5 reports
HYPOXIA5 reports
INFECTION5 reports
KIDNEY TRANSPLANT REJECTION5 reports
LYMPHOCYTE COUNT DECREASED5 reports
MATERNAL EXPOSURE DURING PREGNANCY5 reports
METABOLIC ACIDOSIS5 reports
NERVOUSNESS5 reports
NEUROPATHY PERIPHERAL5 reports
NEUTROPHIL COUNT INCREASED5 reports
OLIGURIA5 reports
OXYGEN SATURATION DECREASED5 reports
PLATELET COUNT DECREASED5 reports
SHOCK5 reports
ASPIRATION4 reports
BLOOD ALKALINE PHOSPHATASE INCREASED4 reports
CARDIAC DISORDER4 reports
CARDIO RESPIRATORY ARREST4 reports
CARDIOMYOPATHY4 reports
CHEST PAIN4 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION4 reports
ELECTROCARDIOGRAM ABNORMAL4 reports
ELECTROCARDIOGRAM QT PROLONGED4 reports

Report Outcomes

Out of 364 classified reports for SODIUM NITROPRUSSIDE:

Serious 92.9%Non-Serious 7.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male161 (51.6%)
Female150 (48.1%)
Unknown1 (0.3%)

Reports by Age

Age 5913 reports
Age 5010 reports
Age 7110 reports
Age 29 reports
Age 168 reports
Age 577 reports
Age 617 reports
Age 677 reports
Age 136 reports
Age 186 reports
Age 236 reports
Age 496 reports
Age 546 reports
Age 696 reports
Age 736 reports
Age 746 reports
Age 766 reports
Age 115 reports
Age 175 reports
Age 405 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with SODIUM NITROPRUSSIDE?

This profile reflects 1,403 FDA FAERS reports that mention SODIUM NITROPRUSSIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for SODIUM NITROPRUSSIDE?

Frequently reported terms in FAERS include RENAL FAILURE, PAIN, INJURY, ANXIETY, UNEVALUABLE EVENT, FEAR. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures SODIUM NITROPRUSSIDE?

Labeling and FAERS entries often list EXELA PHARMA SCIENCES, LLC in connection with SODIUM NITROPRUSSIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.